The main purpose of this legislation is to update and extend a program aimed at preventing and treating sickle cell disease, which is a serious genetic blood disorder. The law seeks to enhance the support for individuals affected by this condition and to improve the overall management of the disease and its complications. Key provisions of the law include changes to how sickle cell disease is addressed within the Public Health Service Act. The legislation broadens the focus from just treating sickle cell disease to also preventing and managing its complications.